Azenta, Inc.

Azenta, Inc.

AZTA
Azenta, Inc.US flagNASDAQ Global Select
23.86
USD
+0.43
- -
1.10BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
6.41
7.24
8.2
6.34
7.58
8.96
4.64
5.28
6.92
7.42
8.32
12.58
12.98
12.99
Basic EPS, GAAP
-0.03
0.47
0.21
-1.01
0.9
1.65
6.08
0.88
1.49
28.48
-0.22
-3.62
-1.22
-3.88
Free Cash Flow per Basic Share
0.77
0.72
0.41
0.39
1.2
0.87
0.93
-0.03
1.31
-7.26
-0.51
0.27
0.84
0.63
Dividend per Share
0.32
0.34
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.1
- -
- -
- -
- -
Book Value per Share
-15.4
-15.1
-15.12
-16.29
-15.54
-14.09
-8.13
-7.48
-6.32
22.11
24.78
32.4
31.06
27.11
Tangible Book Value per Share
7.2
7.11
6.75
3.94
4.56
5.14
5.54
7.45
9.02
35.67
21.97
20.88
20.17
19.83
Basic Weighted Avg Shares
66
67
67
69
70
70
72
74
74
75
66
46
46
46
Sales/Revenue/Turnover
422
483
553
434
527
632
334
389
514
555
551
573
594
596
Operating Margin (%)
-2.47
0.74
3.91
-1.58
3.31
5.09
-13.78
-9.25
-5.98
-4.22
-10.28
-6.95
-3.65
-3.28
Depreciation Expense
24
23
25
28
28
37
54
65
65
54
86
91
61
57
Net Income, GAAP
-2
31
14
-69
63
117
437
65
111
2,133
-15
-165
-56
-178
Effective Tax Rate (%)
- -
- -
19.25
- -
23.28
- -
- -
- -
- -
- -
- -
- -
- -
80.22
Profit Margin (%)
-0.52
6.5
2.57
-16.01
11.87
18.46
130.89
16.69
21.56
383.95
-2.65
-28.76
-9.39
-29.88
Working Capital
262
260
243
180
205
399
375
438
432
2,229
1,208
627
471
470
LT Debt
- -
7
- -
- -
- -
194
50
68
95
49
60
57
51
56
Total Equity
633
643
632
554
608
718
1,139
1,214
1,325
3,363
2,534
1,768
1,727
1,555
Return on Invested Capital (%)
- -
- -
2.7
- -
2.28
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
-1.44
- -
-5.73
- -
- -
- -
- -
- -
- -
- -
- -
-7.82
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-0.89
-10.58
-3.85
-13.36

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'26
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
51
54
56
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
46
46
46
Market Capitalization
1,314
1,524
970

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'26
Mar'26
Total Current Assets
708
780
727
Cash, Cash Equivalents & STI
341
410
381
Accounts Receivable, Net
142
142
131
Inventories
75
82
79
Total Current Liabilities
238
267
257
Payables & Accruals
82
99
92
ST Debt
- -
- -
- -
Deferred Revenue
58
70
75

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
18.65%
21.16%
-2.31%
Free Cash Flow
-540.73%
-1,099.22%
210.29%
Net Income, GAAP
225.4%
551.29%
-66.18%
Sales/Revenue/Turnover
3.61%
9.43%
3.55%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
142
136
144
170
573
2025
147
143
144
159
594
2026
149
145
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.28
-2.47
-0.12
-0.11
-3.62
2025
-0.24
-1.04
-1.15
1.11
-1.22
2026
-0.34
-3.49
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
John Marotta
Full Time Employees
3,000
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Address
15 Elizabeth Drive Burlington MA United States of America 01824
IPO Date
Feb 2, 1995
Website
azenta.com
Business
Azenta, Inc. Azenta, Inc. (Nasdaq: AZTA) provides life sciences sample exploration and management solutions to pharmaceutical, biotechnology, academic, and healthcare institutions worldwide. The company offers consumables and instruments including 2D sample storage tubes and bench-top equipment from brands such as FluidX, Ziath, and 4titude; automated stores and cryogenics systems; sample storage and repository services through BioStorage Technologies; GENEWIZ multiomics and synthesis solutions encompassing next-generation sequencing, genomics, and transgene expression cassettes; sample management LIMS software like FreezerPro and Limfinity; cold chain solutions from B Medical Systems including temperature-controlled storage and transportation; and biological sample preparation from Matrical Bioscience. Azenta operates globally across North America, Europe, and Asia from its headquarters in Burlington, Massachusetts, where it was rebranded from Brooks Automation in December 2021 following a corporate restructuring that divested its semiconductor solutions group. Recent developments include a May 2025 strategic partnership with Form Bio to integrate GENEWIZ sequencing with AI-driven AAV gene therapy analysis for improved vector safety and development speed; and a November 2025 collaboration with the PRECEDE Foundation to provide biorepository storage and logistics for pancreatic cancer early detection research.

Company News

APIChat
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA

  • Azenta Inc (AZTA) Stock Up 5.4% and Still Undervalued -- GF Score: 72/100

  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA

  • Azenta, Inc. (AZTA) Securities Fraud Investigation - Levi & Korsinsky

  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA

  • Investors in Azenta, Inc. (AZTA) Warned of Potential Securities Fraud - Contact Levi & Korsinsky Today

  • Azenta, Inc. (AZTA) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

  • Securities Fraud Investigation Into Azenta, Inc. (AZTA) Continues -- Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

  • Securities Fraud Investigation Into Azenta, Inc. (AZTA) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

  • Securities Fraud Investigation Into Azenta, Inc. (AZTA) Continues -- Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

  • Securities Fraud Investigation Into Azenta, Inc. (AZTA) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

  • Azenta Publishes 2025 Environmental, Social, and Governance (ESG) Report

  • INVESTOR ALERT: Pomerantz Law Firm Investigates ClaimsOn Behalf of Investors of Azenta, Inc. - AZTA

  • Levi & Korsinsky Announces Investigation of Securities Claims Against Azenta, Inc. (AZTA)

  • Levi & Korsinsky Announces Investigation of Securities Claims Against Azenta, Inc. (AZTA)

  • AZTA Investor Alert: Levi & Korsinsky Investigates Azenta, Inc. (AZTA) for Potential Securities Fraud

  • Bragar Eagel & Squire, P.C. is Investigating Azenta, Inc. (NASDAQ:AZTA) on Behalf of Azenta Stockholders and Encourages Investors to Contact the Firm

  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA

  • AZTA SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

  • AZTA SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations